Cargando…

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant

Given periodic outbreaks of fatal human infections caused by coronaviruses, development of an optimal coronavirus vaccine platform capable of rapid production is an ongoing priority. This chapter describes the use of an insect cell expression system for rapid production of a recombinant vaccine agai...

Descripción completa

Detalles Bibliográficos
Autores principales:	McPherson, Clifton, Chubet, Richard, Holtz, Kathy, Honda-Okubo, Yoshikazu, Barnard, Dale, Cox, Manon, Petrovsky, Nikolai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139448/ https://www.ncbi.nlm.nih.gov/pubmed/27076136 http://dx.doi.org/10.1007/978-1-4939-3387-7_14

Ejemplares similares

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy
por: Heddle, Robert, et al.
Publicado: (2013)

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice
por: Zhou, Zhimin, et al.
Publicado: (2006)

Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
por: Heddle, Robert, et al.
Publicado: (2019)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021)

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2021)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
por: Li, Lei, et al.
Publicado: (2022)

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
por: Stewart, Erica L., et al.
Publicado: (2022)

An Advax-Adjuvanted Inactivated Cell-Culture Derived Japanese Encephalitis Vaccine Induces Broadly Neutralising Anti-Flavivirus Antibodies, Robust Cellular Immunity and Provides Single Dose Protection
por: Komiya, Tomoyoshi, et al.
Publicado: (2021)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2023)

Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation
por: Wang, Lixin, et al.
Publicado: (2019)

Influence of Oxidation Degree on the Physicochemical Properties of Oxidized Inulin
por: Afinjuomo, Franklin, et al.
Publicado: (2020)

Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine
por: Wang, Keyang, et al.
Publicado: (2006)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
por: Li, Lei, et al.
Publicado: (2021)

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
por: Wanandy, Troy, et al.
Publicado: (2019)

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
por: Lobigs, Mario, et al.
Publicado: (2010)

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective
por: Baldwin, Jeremy, et al.
Publicado: (2021)

Inulin: A New Adjuvant With Unknown Mode of Action
por: Skwarczynski, Mariusz
Publicado: (2016)

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)

Design and Characterization of Inulin Conjugate for Improved Intracellular and Targeted Delivery of Pyrazinoic Acid to Monocytes
por: Afinjuomo, Franklin, et al.
Publicado: (2019)

Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery
por: Afinjuomo, Franklin, et al.
Publicado: (2019)

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants
por: Cristillo, AD, et al.
Publicado: (2009)

Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019)

Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss
por: Holtz, Kathleen M, et al.
Publicado: (2014)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
por: Tabynov, Kairat, et al.
Publicado: (2022)

Vaccine Adjuvant Nanotechnologies
por: Barclay, T., et al.
Publicado: (2017)

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
por: Adney, Danielle R., et al.
Publicado: (2019)

Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line
por: Hashimoto, Yoshifumi, et al.
Publicado: (2017)

Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255
por: Stewart, Erica, et al.
Publicado: (2022)

Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: In silico studies of medicinal plants of North-East India
por: Solo, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h8j20pajggg5v60bv26djuqta